CA Stock MarketDetailed Quotes

METX ME Therapeutics Holding Inc

Watchlist
  • 9.000
  • 0.0000.00%
15min DelayMarket Closed Apr 11 15:59 ET
235.71MMarket Cap-180.00P/E (TTM)

ME Therapeutics Holding Inc Key Stats

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q2)Feb 28, 2025
(Q1)Nov 30, 2024
(FY)Aug 31, 2024
(Q4)Aug 31, 2024
(Q3)May 31, 2024
(Q2)Feb 29, 2024
(Q1)Nov 30, 2023
(FY)Aug 31, 2023
(Q4)Aug 31, 2023
(Q3)May 31, 2023
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
-108.83%-207.27K
45.24%-145.34K
-117.00%-657.92K
-48.92%-150.26K
2.58%-142.98K
-99.25K
-1,078.96%-265.43K
-123.46%-303.2K
-100.9K
-146.77K
Net income from continuing operations
-39.37%-199.98K
12.17%-301.36K
80.14%-1.29M
89.41%-312.04K
85.81%-495.99K
---143.49K
-431.40%-343.11K
-4,372.64%-6.52M
---2.95M
---3.49M
Depreciation and amortization
186,063.64%20.48K
116,822.22%10.52K
-20.41%39
-25.00%9
-16.67%10
--11
--9
-19.67%49
--12
--12
Remuneration paid in stock
159.73%17.97K
-26.49%152.6K
17.45%690.89K
-31.20%170.87K
-10.11%305.5K
--6.92K
--207.6K
4,198.90%588.22K
--248.35K
--339.87K
Other non cashItems
29.32%3.79K
-36.70%2.79K
-99.85%8.58K
--0
-99.96%1.25K
--2.93K
--4.4K
51,625.44%5.59M
--2.58M
--2.99M
Change In working capital
-244.06%-49.53K
92.63%-9.89K
-247.48%-62.8K
-165.85%-9.1K
129.20%46.25K
--34.38K
-419.42%-134.33K
394.77%42.58K
--13.82K
--20.18K
-Change in receivables
-90.17%2.26K
57.54%-10.1K
-160.76%-9.37K
-239.08%-3.52K
-228.20%-5.05K
--22.98K
---23.78K
175.05%15.42K
---1.04K
---1.54K
-Change in prepaid assets
-53.06%23.45K
-45.72%-59.21K
47.87%-7.87K
-41.89%-21.74K
-81.57%4.55K
--49.95K
---40.63K
-583.97%-15.1K
---15.32K
--24.7K
-Change in payables and accrued expense
-95.13%-75.23K
184.98%59.41K
-207.80%-45.56K
-46.42%16.17K
1,665.61%46.75K
---38.56K
-266.26%-69.92K
408.48%42.26K
--30.18K
---2.99K
Cash from discontinued investing activities
Operating cash flow
-108.83%-207.27K
45.24%-145.34K
-117.00%-657.92K
-48.92%-150.26K
2.58%-142.98K
---99.25K
-1,078.96%-265.43K
-123.46%-303.2K
---100.9K
---146.77K
Investing cash flow
Cash flow from continuing investing activities
-154.04K
-19.73K
0
0
0
757.44K
0
Net PPE purchase and sale
---154.04K
---8.83K
----
----
----
----
----
----
----
----
Net business purchase and sale
----
----
--0
--0
----
----
----
--757.44K
--0
----
Net other investing changes
--0
---10.89K
----
----
----
----
----
----
----
----
Cash from discontinued investing activities
Investing cash flow
---154.04K
---19.73K
--0
--0
--0
----
----
--757.44K
--0
----
Financing cash flow
Cash flow from continuing financing activities
1.03M
-5.45K
1,204.91%1.51M
-106.49%-7.5K
450K
-17.48%115.53K
115.53K
0
Net issuance payments of debt
---16.34K
---5.45K
---40K
--0
--0
----
----
--0
--0
--0
Net common stock issuance
----
----
1,246.03%1.56M
--0
----
----
----
--115.53K
----
----
Proceeds from stock option exercised by employees
----
----
---7.5K
----
----
----
----
--0
----
----
Cash from discontinued financing activities
Financing cash flow
--1.03M
---5.45K
1,204.91%1.51M
-106.49%-7.5K
--450K
----
----
-17.48%115.53K
--115.53K
--0
Net cash flow
Beginning cash position
247.43%1.33M
131.28%1.5M
736.35%647.15K
161.57%1.65M
6,066.33%1.35M
--381.72K
62.64%647.15K
5.91%77.38K
--632.52K
--21.85K
Current changes in cash
-30.38%672.35K
35.76%-170.52K
49.11%849.58K
-1,178.77%-157.76K
-49.72%307.02K
--965.75K
-358.99%-265.43K
13,104.36%569.77K
--14.62K
--610.67K
End cash Position
48.32%2M
247.43%1.33M
131.28%1.5M
131.28%1.5M
161.57%1.65M
--1.35M
-23.72%381.72K
736.35%647.15K
--647.15K
--632.52K
Free cash from
-264.04%-361.31K
41.91%-154.18K
-117.00%-657.92K
-48.92%-150.26K
2.58%-142.98K
---99.25K
-1,078.96%-265.43K
-123.46%-303.2K
---100.9K
---146.77K
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
Unqualified Opinion with Explanatory Notes
--
--
--
--
Unqualified Opinion with Explanatory Notes
--
--
(Q2)Feb 28, 2025(Q1)Nov 30, 2024(FY)Aug 31, 2024(Q4)Aug 31, 2024(Q3)May 31, 2024(Q2)Feb 29, 2024(Q1)Nov 30, 2023(FY)Aug 31, 2023(Q4)Aug 31, 2023(Q3)May 31, 2023
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities -108.83%-207.27K45.24%-145.34K-117.00%-657.92K-48.92%-150.26K2.58%-142.98K-99.25K-1,078.96%-265.43K-123.46%-303.2K-100.9K-146.77K
Net income from continuing operations -39.37%-199.98K12.17%-301.36K80.14%-1.29M89.41%-312.04K85.81%-495.99K---143.49K-431.40%-343.11K-4,372.64%-6.52M---2.95M---3.49M
Depreciation and amortization 186,063.64%20.48K116,822.22%10.52K-20.41%39-25.00%9-16.67%10--11--9-19.67%49--12--12
Remuneration paid in stock 159.73%17.97K-26.49%152.6K17.45%690.89K-31.20%170.87K-10.11%305.5K--6.92K--207.6K4,198.90%588.22K--248.35K--339.87K
Other non cashItems 29.32%3.79K-36.70%2.79K-99.85%8.58K--0-99.96%1.25K--2.93K--4.4K51,625.44%5.59M--2.58M--2.99M
Change In working capital -244.06%-49.53K92.63%-9.89K-247.48%-62.8K-165.85%-9.1K129.20%46.25K--34.38K-419.42%-134.33K394.77%42.58K--13.82K--20.18K
-Change in receivables -90.17%2.26K57.54%-10.1K-160.76%-9.37K-239.08%-3.52K-228.20%-5.05K--22.98K---23.78K175.05%15.42K---1.04K---1.54K
-Change in prepaid assets -53.06%23.45K-45.72%-59.21K47.87%-7.87K-41.89%-21.74K-81.57%4.55K--49.95K---40.63K-583.97%-15.1K---15.32K--24.7K
-Change in payables and accrued expense -95.13%-75.23K184.98%59.41K-207.80%-45.56K-46.42%16.17K1,665.61%46.75K---38.56K-266.26%-69.92K408.48%42.26K--30.18K---2.99K
Cash from discontinued investing activities
Operating cash flow -108.83%-207.27K45.24%-145.34K-117.00%-657.92K-48.92%-150.26K2.58%-142.98K---99.25K-1,078.96%-265.43K-123.46%-303.2K---100.9K---146.77K
Investing cash flow
Cash flow from continuing investing activities -154.04K-19.73K000757.44K0
Net PPE purchase and sale ---154.04K---8.83K--------------------------------
Net business purchase and sale ----------0--0--------------757.44K--0----
Net other investing changes --0---10.89K--------------------------------
Cash from discontinued investing activities
Investing cash flow ---154.04K---19.73K--0--0--0----------757.44K--0----
Financing cash flow
Cash flow from continuing financing activities 1.03M-5.45K1,204.91%1.51M-106.49%-7.5K450K-17.48%115.53K115.53K0
Net issuance payments of debt ---16.34K---5.45K---40K--0--0----------0--0--0
Net common stock issuance --------1,246.03%1.56M--0--------------115.53K--------
Proceeds from stock option exercised by employees -----------7.5K------------------0--------
Cash from discontinued financing activities
Financing cash flow --1.03M---5.45K1,204.91%1.51M-106.49%-7.5K--450K---------17.48%115.53K--115.53K--0
Net cash flow
Beginning cash position 247.43%1.33M131.28%1.5M736.35%647.15K161.57%1.65M6,066.33%1.35M--381.72K62.64%647.15K5.91%77.38K--632.52K--21.85K
Current changes in cash -30.38%672.35K35.76%-170.52K49.11%849.58K-1,178.77%-157.76K-49.72%307.02K--965.75K-358.99%-265.43K13,104.36%569.77K--14.62K--610.67K
End cash Position 48.32%2M247.43%1.33M131.28%1.5M131.28%1.5M161.57%1.65M--1.35M-23.72%381.72K736.35%647.15K--647.15K--632.52K
Free cash from -264.04%-361.31K41.91%-154.18K-117.00%-657.92K-48.92%-150.26K2.58%-142.98K---99.25K-1,078.96%-265.43K-123.46%-303.2K---100.9K---146.77K
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ----Unqualified Opinion with Explanatory Notes--------Unqualified Opinion with Explanatory Notes----

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Market Insights

Dividend Kings of Canada Dividend Kings of Canada

Dividend Kings In Canada are companies that have increased their Dividend per share for the most consecutive years, reflecting a strong business model and robust financials, and are likely to outperform the market with less volatility. Dividend Kings In Canada are companies that have increased their Dividend per share for the most consecutive years, reflecting a strong business model and robust financials, and are likely to outperform the market with less volatility.

Unlock Now